---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-068701"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:14:19.630815+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio schedules investor webcast for June 11 to discuss Buntanetap progress

## Summary
- Webcast scheduled for June 11, 2024 at 4:30pm ET; registration via Zoom link provided.
- Topics include recent Buntanetap developments, upcoming clinical trial plans, and company progress.
- Buntanetap is a late-stage drug candidate for Alzheimer's and Parkinson's diseases.
- No specific data or results disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-24-068701
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/0001104659-24-068701-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/tm2416510d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-068701
- JSON: https://secwatch.observer/filing/0001104659-24-068701.json
- Plain text: https://secwatch.observer/filing/0001104659-24-068701.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.